Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer
Authors:
- Marko DammMDMarko Damm
- Jonas RosendahlJRJonas Rosendahl
- Güralp O. CeyhanGCGüralp O. Ceyhan
- Daniel SchmidDSDaniel Schmid
- Jan G. D'HAeseJDJan G. D'HAese
- Jens WernerJWJens Werner
- Stefan BoeckSBStefan Boeck
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 20 (6) , 1131-1138
Abstract
No abstract availableKeywords
Funding Information
- German research association/Deutsche Forschungsgemeinschaft (401299842)
This publication has 27 references indexed in Scilit:
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014
- Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm?The Oncologist, 2014
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine, 2013
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection PercentagesPLOS Medicine, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic CancerJAMA, 2007
- Redefining the R1 resection in pancreatic cancerBritish Journal of Surgery, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- GRADING OF PATIENTS FOR SURGICAL PROCEDURESAnesthesiology, 1941